NEW YORK (TheStreet) -- RATINGS CHANGES
B/E Aerospace (BEAV) was downgraded at Canaccord Genuity to hold from buy. Twelve-month price target is $98. Company appears less likely to sell itself, Canaccord Genuity said.
B/E Aerospace was downgraded at Jefferies to hold from buy. Valuation call with 12-month price target of $97, Jefferies said.Sotheby's (BID) was initiated with a neutral rating at Goldman Sachs. Twelve-month price target is $45. Consolidated auction sales are up 25% through May, but global economic stability, China, expense leverage and competition pose a risk to valuation, Goldman said. (COP - Get Report) was upgraded at Howard Weil to outperform from sector perform. Twelve-month price target is $90. Management should continue to execute its growth strategy, Howard Weil said. ETR Entergy (ETR) was upgraded at UBS to neutral from sell. Driven by EPS growth from higher utility and EWC guidance, UBS said. Twelve-month price target is $79. Edwards Lifesciences (EW) was upgraded at JMP Securities to outperform from market perform. Twelve-month price target is $97. Estimates were also increased, following positive physician surveys, JMP Securities said. (MU) was upgraded at Bank of America/Merrill Lynch to buy from underperform. Twelve-month price target is $40. Upturn appears sustainable, as the company is seeing higher prices and lower costs, Bank of America/Merrill said. Prosperity Bancshares (PB) was upgraded at Sterne Agee to buy from neutral. Twelve-month price target is $71. Visibility is improving and the company can sustain above-average profitability, Sterne Agee said.